| | | | | | Dakar bat Antigen | | Dakar bat Immune Serum |
|---|
| Immune Sera | HI | NT | Antigens | HI | NT |
|---|
| | Ht/Ho | Ht/Ho | | Ht/Ho | Ht/Ho |
|---|
|
| | NT: LNI in dex. | | | | | | | | Banzi (GP; 3 inj.) | 2560/5120 | | Banzi | 10/160 | | WN (GP; 3 inj.) | 80/320 | | WN | 40/160 | | WN (mice; 3 inj.) | | 1.07/3.40 | | | 0.51/2.05 | | Uganda S (mice; 3 inj.) | | 1.17/3.73 | Uganda S | | 0.85/2.05 |
| | Screening neutralization test with 1.5 dex LD50 challenge dose of registered virus against: dengue 1, Entebbe bat, Ntaya, Spondweni, Uganda S, Usutu, Wesselsbron, West Nile, yellow fever; Zika: Negative; Banzi protection 3/10. | | See also extensive cross-HI results versus other Group B viruses in Reference [4] , and additional information on antigenic relationship in References [11] - [13] . | | |
|